John Lunger is Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (ADAP). They have made 20 open-market trades across 1 company since 2020, most recently 2025-01-17.
CIK 0001784487
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 20 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADAP | 7,510 | $412 |
Shares reported on the most recent Form 4, priced at the 2025-01-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADAP | SELL | 2025-01-17 | 2025-01-17 | $0.58 | $3K | +7.0% | +2.3% | -58.1% |
| ADAP | SELL | 2025-01-13 | 2025-01-15 | $0.58 | $11K | -0.5% | -2.5% | -57.9% |
| ADAP | SELL | 2024-01-16 | 2024-01-17 | $0.69 | $16K | +10.3% | +66.8% | +43.1% |
| ADAP | SELL | 2024-01-11 | 2024-01-12 | $0.85 | $8K | -6.7% | +53.2% | +63.3% |
| ADAP | SELL | 2023-08-01 | 2023-08-01 | $0.91 | $3K | -10.0% | -13.3% | -38.3% |
| ADAP | SELL | 2023-01-17 | 2023-01-17 | $1.86 | $8K | +2.9% | -2.3% | -20.6% |
| ADAP | SELL | 2023-01-11 | 2023-01-12 | $1.73 | $15K | +2.2% | -13.9% | -33.9% |
| ADAP | SELL | 2023-01-04 | 2023-01-04 | $1.69 | $2K | -3.3% | -8.3% | -43.1% |
| ADAP | SELL | 2022-08-01 | 2022-08-01 | $1.77 | $5K | +31.6% | +15.8% | -17.0% |
| ADAP | SELL | 2022-07-05 | 2022-07-05 | $1.68 | $3K | +3.6% | +40.6% | -34.5% |
| ADAP | SELL | 2022-01-18 | 2022-01-18 | $3.19 | $14K | -12.7% | -2.3% | -40.1% |
| ADAP | SELL | 2022-01-11 | 2022-01-13 | $3.56 | $17K | -15.8% | -7.5% | -41.5% |
| ADAP | SELL | 2022-01-04 | 2022-01-05 | $4.06 | $4K | -14.3% | -21.3% | -39.2% |
| ADAP | SELL | 2021-08-02 | 2021-08-02 | $3.58 | $11K | +7.0% | +41.1% | +50.6% |
| ADAP | SELL | 2021-07-02 | 2021-07-02 | $4.26 | $8K | -12.4% | -16.2% | +21.1% |
| ADAP | SELL | 2021-01-19 | 2021-01-19 | $5.67 | $25K | -6.8% | +2.0% | -20.1% |
| ADAP | SELL | 2021-01-04 | 2021-01-05 | $5.33 | $6K | +1.3% | +3.5% | -0.6% |
| ADAP | SELL | 2020-08-03 | 2020-08-04 | $9.25 | $45K | -9.3% | -11.4% | -41.7% |
| ADAP | SELL | 2020-01-14 | 2020-01-15 | $5.13 | $6K | -5.3% | -3.8% | -17.5% |
| ADAP | SELL | 2020-01-06 | 2020-01-07 | $1.20 | $1K | +261.6% | +232.0% | +140.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.